
Loading, please wait...

Loading, please wait...

This study followed 568 patients with type 2 diabetes (T2D) and 376 controls for 16.8 years, assessing the predictive value of the TyG index for all-cause mortality and major adverse cardiovascular events (MACE). Higher TyG index values were linked to increased mortality and complications like diabetic kidney disease and neuropathy. The effect was strongest in individuals aged 57–74, supporting the TyG index's use in clinical risk stratification.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This study followed 568 patients with type 2 diabetes (T2D) and 376 controls for 16.8 years, assessing the predictive value of the TyG index for all-cause mortality and major adverse cardiovascular events (MACE). Higher TyG index values were linked to increased mortality and complications like diabetic kidney disease and neuropathy. The effect was strongest in individuals aged 57–74, supporting the TyG index's use in clinical risk stratification.
2 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday